Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-10
DOI
10.1038/s41431-021-00811-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy
- (2020) Pietro Spitali et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine
- (2020) Nalinda B. Wasala et al. Expert Opinion on Drug Discovery
- Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
- (2020) Ignazio Maggio et al. GENE THERAPY
- Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy
- (2020) Nalinda B. Wasala et al. MOLECULAR THERAPY
- AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
- (2020) Helena Costa Verdera et al. MOLECULAR THERAPY
- Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
- (2020) A. Moretti et al. NATURE MEDICINE
- Engineering adeno-associated virus vectors for gene therapy
- (2020) Chengwen Li et al. NATURE REVIEWS GENETICS
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
- (2020) Yu Zhang et al. Science Advances
- rAAVrh74.MCK.GALGT2 Protects Against Loss of Hemodynamic Function in the Aging mdx Mouse Heart
- (2019) Rui Xu et al. MOLECULAR THERAPY
- CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells
- (2019) Yi-Li Min et al. Science Advances
- In vivo RNA editing of point mutations via RNA-guided adenosine deaminases
- (2019) Dhruva Katrekar et al. NATURE METHODS
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
- (2019) Christopher E. Nelson et al. NATURE MEDICINE
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
- (2019) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- Therapeutic developments for Duchenne muscular dystrophy
- (2019) Ingrid E. C. Verhaart et al. Nature Reviews Neurology
- Unified energetics analysis unravels SpCas9 cleavage activity for optimal gRNA design
- (2019) Dong Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening
- (2019) Mei Baker et al. JAMA Neurology
- AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice
- (2019) Michael E. Nance et al. MOLECULAR THERAPY
- Exons 45-55 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene
- (2019) Yusuke Echigoya et al. MOLECULAR THERAPY
- A cytosine deaminase for programmable single-base RNA editing
- (2019) Omar O. Abudayyeh et al. SCIENCE
- Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
- (2019) Maria K. Tsoumpra et al. EBioMedicine
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- Surrogate gene therapy for muscular dystrophy
- (2019) Kay E. Davies et al. NATURE MEDICINE
- CRISPR RNAs trigger innate immune responses in human cells
- (2018) Sojung Kim et al. GENOME RESEARCH
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- Cyclic Peptides to Improve Delivery and Exon Skipping of Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy
- (2018) Silvana M.G. Jirka et al. MOLECULAR THERAPY
- Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs
- (2018) Paul Vogel et al. NATURE METHODS
- Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts
- (2018) Joshua Lee et al. PLoS One
- Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies
- (2018) Pietro Spitali et al. Journal of Cachexia Sarcopenia and Muscle
- Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy
- (2018) Gonzalo Cordova et al. Frontiers in Genetics
- Personalized gene and cell therapy for Duchenne Muscular Dystrophy
- (2018) Florian Barthélémy et al. NEUROMUSCULAR DISORDERS
- Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates
- (2018) Kenji Rowel Q. Lim et al. MOLECULAR THERAPY
- High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
- (2018) Dimitrios L. Wagner et al. NATURE MEDICINE
- Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy
- (2017) Yusuke Echigoya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice
- (2017) Antanina Voit et al. Nature Communications
- Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
- (2017) Caroline Le Guiner et al. Nature Communications
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model
- (2017) Karima Relizani et al. Molecular Therapy-Nucleic Acids
- Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
- (2017) Kunwoo Lee et al. Nature Biomedical Engineering
- Lentiviral vectors can be used for full-length dystrophin gene therapy
- (2017) John R. Counsell et al. Scientific Reports
- Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules
- (2016) Mark G. Rae et al. JOURNAL OF NEUROPHYSIOLOGY
- The Pathogenesis and Therapy of Muscular Dystrophies
- (2015) Simon Guiraud et al. Annual Review of Genomics and Human Genetics
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy
- (2015) David G. Ousterout et al. Nature Communications
- What Can We Learn From Clinical Trials of Exon Skipping for DMD?
- (2014) Qi-long Lu et al. Molecular Therapy-Nucleic Acids
- Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy
- (2013) Taeyoung Koo et al. HUMAN GENE THERAPY
- Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
- (2013) Louis G. Chicoine et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now